Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 134th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
ADAG	ADAGENE INC	$114.82M	-32.20%	-20.50%	-19.21%	126.40%	0.31	5.02	100.00%	-220.80%	-221.64%
AKTS	AKTIS ONCOLOGY INC	$927.36M	-26.90%	-18.10%	-17.60%	-27.20%	0.16	14.22	100.00%	-706.80%	-706.81%
GANX	GAIN THERAPEUTICS INC	$46.31M	-133.20%	-102.40%	-161.58%	2,666.00%	0.30	5.36	N/A	N/A	N/A
MGTX	MEIRAGTX HOLDINGS PLC	$897.17M	85.30%	24.10%	25.24%	43.40%	0.91	4.63	97.20%	19.50%	22.56%
ICU	SEASTAR MEDICAL HOLDING CORP	$4.45M	-261.10%	-149.20%	-3,124.09%	666.80%	10.32	1.03	92.60%	-678.20%	-676.77%
BCTX	BRIACELL THERAPEUTICS CORP	$29.60M	-179.90%	-145.20%	-230.33%	-492.20%	0.52	2.76	N/A	N/A	N/A
ALDX	ALDEYRA THERAPEUTICS INC	$38.87M	-48.00%	-33.30%	-51.22%	245.10%	0.23	5.45	N/A	N/A	N/A
NERV	MINERVA NEUROSCIENCES INC	$114.62M	N/A	-308.00%	-303.76%	-296.50%	-1.89	33.02	N/A	N/A	N/A
VERA	VERA THERAPEUTICS INC	$2.03B	-90.00%	-70.50%	-99.48%	-87.60%	0.40	7.91	67.90%	-4,041.20%	-3,968.71%
PRAX	PRAXIS PRECISION MEDICINES INC	$9.17B	-29.40%	-28.20%	-28.54%	-45.50%	0.04	14.53	N/A	N/A	N/A
NGNE	NEUROGENE INC	$495.37M	-44.40%	-40.60%	-33.13%	-66.80%	0.07	19.97	N/A	N/A	N/A
CCCC	C4 THERAPEUTICS INC	$362.44M	-37.70%	-26.40%	-31.33%	-30.30%	0.45	5.17	100.00%	-282.20%	-281.85%
OVID	OVID THERAPEUTICS INC	$479.38M	-23.40%	-20.80%	-20.49%	-24.70%	0.12	11.97	100.00%	-2,971.30%	-2,971.33%
MIRM	MIRUM PHARMACEUTICALS INC	$6.14B	-734.00%	-95.00%	-119.56%	-130.70%	-19.95	2.07	81.70%	-134.80%	-132.53%
WHWK	WHITEHAWK THERAPEUTICS INC	$180.57M	-55.70%	-51.60%	-51.02%	-89.50%	0.07	16.47	N/A	N/A	N/A
DBVT	DBV TECHNOLOGIES SA	$692.60M	-120.90%	-88.30%	-131.46%	4,090.30%	0.45	3.24	100.00%	-5,392.20%	-5,364.24%
CGON	CG ONCOLOGY INC	$6.65B	-24.60%	-23.40%	-23.74%	-25.20%	0.06	21.70	-104.80%	-3,851.10%	-3,851.09%
MSLE	SATELLOS BIOSCIENCE INC	$140.56M	N/A	N/A	N/A	N/A	0.17	6.93	N/A	N/A	N/A
OCS	OCULIS HOLDING AG	$520.47M	-39.30%	-33.50%	-37.70%	-61.80%	0.11	10.41	100.00%	-8,598.90%	-8,515.90%
CABA	CABALETTA BIO INC	$276.12M	-106.80%	-83.60%	-64.77%	-707.50%	0.19	6.55	N/A	N/A	N/A
EIKN	EIKON THERAPEUTICS INC	$324.03M	-258.10%	-46.00%	-54.86%	-43.70%	0.84	7.21	N/A	N/A	N/A
TARA	PROTARA THERAPEUTICS INC	$155.77M	-46.10%	-42.70%	-55.18%	-53.10%	0.11	9.01	N/A	N/A	N/A
VOR	VOR BIOPHARMA INC	$1.19B	-830.40%	277.90%	294.31%	490.70%	-4.62	13.50	N/A	N/A	N/A
MAZE	MAZE THERAPEUTICS INC	$1.88B	-38.40%	-32.60%	-30.77%	-48.70%	0.19	14.14	100.00%	-757.40%	-743.50%
IMMX	IMMIX BIOPHARMA INC	$657.09M	-24.90%	-23.50%	-13.76%	-599.90%	0.03	33.72	N/A	N/A	N/A
BIVI	BIOVIE INC	$12.12M	-174.90%	-138.40%	-337.55%	-5,020.50%	0.69	2.40	N/A	N/A	N/A
ELDN	ELEDON PHARMACEUTICALS INC	$178.63M	-185.00%	-64.00%	-92.35%	-77.50%	1.20	6.30	N/A	N/A	N/A
STOK	STOKE THERAPEUTICS INC	$1.75B	-67.30%	-58.50%	-71.95%	-101.40%	0.15	7.24	100.00%	-862.10%	-912.34%
RGNX	REGENXBIO INC	$505.18M	-204.00%	-42.50%	-34.89%	-26.10%	2.15	4.74	87.50%	-113.90%	-90.30%
RCUS	ARCUS BIOSCIENCES INC	$2.51B	-91.70%	-46.70%	-71.41%	-65.00%	1.29	3.34	100.00%	-453.00%	-442.00%
NBP	NOVABRIDGE BIOSCIENCES	$98.65M	-37.90%	-34.40%	-36.71%	-265.40%	0.15	7.64	N/A	N/A	N/A
OBX	OBSIDIAN THERAPEUTICS INC	$775.88M	N/A	N/A	N/A	N/A	0.06	12.29	N/A	N/A	N/A
AGMB	AGOMAB THERAPEUTICS NV	$309.97M	N/A	N/A	N/A	N/A	0.10	12.88	N/A	N/A	N/A
NVCT	NUVECTIS PHARMA INC	$696.03M	-119.90%	-91.60%	-37.92%	374.70%	0.11	9.92	N/A	N/A	N/A
BMEA	BIOMEA FUSION INC	$42.30M	-131.30%	-52.50%	-145.60%	272.80%	2.70	2.17	N/A	N/A	N/A
PEPG	PEPGEN INC	$301.98M	-58.20%	-48.90%	-63.43%	-62.60%	0.24	8.70	N/A	N/A	N/A
PVLA	PALVELLA THERAPEUTICS INC	$2.23B	-44.40%	-36.80%	-28.52%	-203.80%	0.21	16.01	N/A	N/A	N/A
IDYA	IDEAYA BIOSCIENCES INC	$3.08B	-39.50%	-36.00%	-37.51%	-45.80%	0.11	9.05	100.00%	-1,149.60%	-1,149.62%
ORKA	ORUKA THERAPEUTICS INC	$7.15B	0.00%	0.00%	-0.01%	0.00%	0.03	29.62	N/A	N/A	N/A
NGEN	NERVGEN PHARMA CORP	$200.06M	-377.40%	-59.90%	-47.04%	76.60%	0.93	2.07	N/A	N/A	N/A
JBIO	JADE BIOSCIENCES INC	$1.12B	-42.80%	-40.10%	-35.74%	-54.40%	0.07	16.03	N/A	N/A	N/A
AMLX	AMYLYX PHARMACEUTICALS INC	$3.89B	-41.50%	-38.90%	-21.53%	-75.80%	0.04	26.81	N/A	N/A	N/A
TNXP	TONIX PHARMACEUTICALS HOLDING CORP	$58.49M	-81.00%	-70.20%	-90.31%	-423.20%	0.22	4.57	89.30%	-420.40%	-420.45%
MBX	MBX BIOSCIENCES INC	$2.78B	-34.40%	-32.70%	-30.52%	-42.50%	0.06	19.58	N/A	N/A	N/A
ACET	ADICET BIO INC	$26.03M	-69.70%	-57.00%	-81.07%	-77.10%	0.26	6.09	N/A	N/A	N/A
CGEM	CULLINAN THERAPEUTICS INC	$667.39M	-59.10%	-52.90%	-72.04%	-76.60%	0.15	7.43	N/A	N/A	N/A
MIST	MILESTONE PHARMACEUTICALS INC	$64.74M	-288.40%	-58.30%	-45.91%	-53.90%	8.97	8.13	98.00%	-3,585.60%	-3,124.16%
BDTX	BLACK DIAMOND THERAPEUTICS INC	$84.48M	-44.00%	-34.10%	-44.00%	-41.90%	0.31	6.92	N/A	N/A	N/A
IKT	INHIBIKASE THERAPEUTICS INC	$213.21M	-40.50%	-38.40%	-36.64%	-67.30%	0.07	15.34	N/A	N/A	N/A
ERAS	ERASCA INC	$5.50B	-61.70%	-53.80%	-32.25%	-59.90%	0.09	14.89	N/A	N/A	N/A
NMAD	NOMAD POWER SOLUTIONS INC	$37.84M	-75.10%	-62.70%	-34.30%	-113.60%	0.07	12.87	N/A	N/A	N/A
DSGN	DESIGN THERAPEUTICS INC	$670.46M	-35.50%	-33.40%	-36.31%	-37.50%	0.07	16.78	N/A	N/A	N/A
NRXP	NRX PHARMACEUTICALS INC	$94.82M	N/A	-126.90%	-7,809.79%	89.60%	-201.94	0.86	46.60%	-691.80%	-658.10%
ALGS	ALIGOS THERAPEUTICS INC	$26.24M	-206.30%	-99.40%	-234.70%	-293.00%	3.17	1.77	100.00%	-197.00%	-192.45%
FTH	FAETH THERAPEUTICS INC	$259.21M	-392.60%	-141.70%	-125.87%	-235.70%	0.07	16.12	N/A	N/A	N/A
VERU	VERU INC	$35.64M	-45.90%	-34.60%	-44.08%	-365.60%	0.31	4.42	N/A	N/A	N/A
TRVI	TREVI THERAPEUTICS INC	$1.95B	-24.80%	-24.00%	-20.08%	-28.20%	0.03	38.86	N/A	N/A	N/A
TLSA	TIZIANA LIFE SCIENCES LTD	$68.69M	-924.30%	-161.80%	-6,444.41%	1,249.60%	220.06	0.76	N/A	N/A	N/A
PMVP	PMV PHARMACEUTICALS INC	$95.93M	-110.20%	-87.10%	-87.88%	-137.60%	0.95	9.81	N/A	N/A	N/A
SVRA	SAVARA INC	$1.02B	-96.90%	-74.20%	-109.64%	-83.70%	0.45	8.55	N/A	N/A	N/A
SGP	SPYGLASS PHARMA INC	$1.10B	-47.50%	-33.40%	-33.24%	-635.20%	0.08	15.24	N/A	N/A	N/A
CRVS	CORVUS PHARMACEUTICALS INC	$897.52M	-35.00%	-32.70%	-30.85%	-38.90%	0.08	13.38	N/A	N/A	N/A
SYRE	SPYRE THERAPEUTICS INC	$9.88B	-29.80%	-27.70%	-24.90%	-33.60%	0.05	27.40	N/A	N/A	N/A
RZLT	REZOLUTE INC	$353.54M	-72.20%	-65.90%	-90.04%	-78.50%	0.12	9.92	N/A	N/A	N/A
HURA	TUHURA BIOSCIENCES INC	$91.40M	-146.80%	-95.80%	-98.55%	-185.60%	0.91	0.48	N/A	N/A	N/A
IRLA	IRULYA THERAPEUTICS INC	$431.49M	N/A	-121.80%	-110.02%	-809.50%	-0.43	14.73	N/A	N/A	N/A
MAIA	MAIA BIOTECHNOLOGY INC	$61.75M	-153.40%	-105.40%	-160.75%	466.70%	0.51	3.41	N/A	N/A	N/A
CNTN	CANTON STRATEGIC HOLDINGS INC	$136.26M	-29.50%	-23.40%	-20.50%	-29.50%	0.24	15.70	100.00%	-6,559.30%	-7,700.14%
TENX	TENAX THERAPEUTICS INC	$73.77M	-60.60%	-56.40%	-60.52%	1,877.20%	0.08	14.01	N/A	N/A	N/A
GNLX	GENELUX CORP	$84.38M	-205.80%	-138.80%	-195.51%	-255.60%	0.63	2.39	N/A	N/A	N/A
ATTO	ATTOVIA THERAPEUTICS INC	$691.63M	N/A	N/A	N/A	N/A	0.04	34.66	N/A	N/A	N/A
IRD	OPUS GENETICS INC	$384.68M	N/A	-179.00%	-159.74%	-955.30%	1.48	9.65	100.00%	-1,726.70%	-1,725.06%
INMB	INMUNE BIO INC	$32.51M	-81.70%	-62.60%	-89.65%	-810.90%	0.19	6.41	N/A	N/A	N/A
SGMT	SAGIMET BIOSCIENCES INC	$729.38M	-29.90%	-27.70%	-21.84%	-57.40%	0.17	6.34	N/A	N/A	N/A
IMTX	IMMATICS NV	$972.98M	-52.20%	-43.00%	-50.11%	-116.70%	0.29	5.03	100.00%	-534.10%	-535.27%
ABVX	ABIVAX SA	$6.98B	-91.10%	-71.50%	-64.02%	-2,522.40%	0.26	5.97	100.00%	-7,979.70%	-4,972.24%
COGT	COGENT BIOSCIENCES INC	$4.97B	-71.10%	-46.50%	-53.06%	-49.30%	0.61	10.99	N/A	N/A	N/A
VSTM	VERASTEM INC	$1.03B	-359.50%	-78.60%	-139.91%	-306.10%	21.73	1.93	86.10%	-178.40%	-176.20%
SPRB	SPRUCE BIOSCIENCES INC	$124.47M	-118.20%	-88.40%	-87.62%	2,139.00%	0.39	4.83	N/A	N/A	N/A
ANVS	ANNOVIS BIO INC	$57.43M	-8,312.80%	-319.00%	6,798.38%	1,061.90%	-1.42	0.88	N/A	N/A	N/A
BNTC	BENITEC BIOPHARMA INC	$315.34M	-28.40%	-27.80%	-25.69%	7,762.40%	0.03	34.00	N/A	N/A	N/A
LCTX	LINEAGE CELL THERAPEUTICS INC	$231.45M	3.10%	1.60%	-3.30%	-13.20%	0.51	5.96	99.30%	16.20%	-28.08%
TECX	TECTONIC THERAPEUTIC INC	$421.70M	-37.70%	-35.60%	-37.86%	-11,071.00%	0.06	19.71	N/A	N/A	N/A
STRO	SUTRO BIOPHARMA INC	$163.03M	N/A	-78.90%	-125.71%	-177.20%	-2.33	2.94	100.00%	-344.20%	-340.93%
KYTX	KYVERNA THERAPEUTICS INC	$319.27M	-86.90%	-65.70%	-94.51%	-82.60%	0.42	7.01	N/A	N/A	N/A
FDMT	4D MOLECULAR THERAPEUTICS INC	$689.52M	-47.10%	-40.10%	-53.24%	-47.40%	0.27	6.15	100.00%	-208.60%	-208.57%
ORIC	ORIC PHARMACEUTICALS INC	$814.71M	-35.40%	-33.40%	-36.56%	-39.70%	0.06	13.19	N/A	N/A	N/A
MGNX	MACROGENICS INC	$140.60M	-142.20%	-18.10%	-16.38%	-12.20%	11.67	2.75	82.70%	-45.40%	-30.51%
ZURA	ZURA BIO LTD	$119.44M	-70.50%	-65.10%	-53.38%	1,096.00%	0.10	11.29	N/A	N/A	N/A
CELC	CELCUITY INC	$3.16B	-1,522.50%	-42.10%	-34.62%	-26.10%	-10.82	14.62	N/A	N/A	N/A
CTNM	CONTINEUM THERAPEUTICS INC	$387.16M	-25.50%	-24.30%	-25.49%	-29.60%	0.05	31.11	N/A	N/A	N/A
IMRX	IMMUNEERING CORP	$240.27M	-33.90%	-32.00%	-38.72%	-52.30%	0.08	13.97	N/A	N/A	N/A
ANNX	ANNEXON INC	$747.79M	-106.80%	-76.80%	-93.13%	-203.90%	0.75	5.79	N/A	N/A	N/A
ENTX	ENTERA BIO LTD	$541.57M	-38.60%	-36.20%	-10.72%	-6,908.30%	0.01	128.41	N/A	N/A	N/A
ARTV	ARTIVA BIOTHERAPEUTICS INC	$198.22M	-45.30%	-41.40%	-30.04%	-75.30%	0.07	19.88	N/A	N/A	N/A
AZR	AZORA THERAPEUTICS INC	$58.43M	N/A	-759.30%	-690.07%	4,465.90%	-0.24	4.43	N/A	N/A	N/A
HELP	HELUS PHARMA INC	$705.62M	-97.00%	-90.40%	-98.07%	-2,604.30%	0.08	10.90	N/A	N/A	N/A
MCRB	SERES THERAPEUTICS INC	$14.27M	-148.30%	-44.40%	-104.35%	-39.90%	2.09	1.65	100.00%	-2,209.60%	-2,209.55%
SION	SIONNA THERAPEUTICS INC	$150.63M	-39.80%	-37.20%	-44.37%	-49.30%	0.10	13.92	N/A	N/A	N/A
CAPR	CAPRICOR THERAPEUTICS INC	$554.09M	-56.70%	-42.70%	-48.07%	-57.60%	0.58	6.77	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Nov 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Xeris Biopharma Holdings (NASDAQ:XERS)

Xeris Biopharma Holdings (NASDAQ:XERS) is the #1 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Xeris Biopharma Holdings (NASDAQ:XERS) is: Value: C, Growth: A, Momentum: A, Sentiment: A, Safety: C, Financials: B, and AI: B.

Xeris Biopharma Holdings (NASDAQ:XERS) has a Due Diligence Score of 39, which is 15 points higher than the biotech industry average of 24.

XERS passed 13 out of 33 due diligence checks and has average fundamentals. Xeris Biopharma Holdings has seen its stock return 129.48% over the past year, overperforming other biotech stocks by 225 percentage points.

Xeris Biopharma Holdings has an average 1 year price target of $17.00, an upside of 2.04% from Xeris Biopharma Holdings's current stock price of $16.66.

Xeris Biopharma Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Xeris Biopharma Holdings, 20% have issued a Strong Buy rating, 60% have issued a Buy, 20% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Regeneron Pharmaceuticals (NASDAQ:REGN)

Regeneron Pharmaceuticals (NASDAQ:REGN) is the #2 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Regeneron Pharmaceuticals (NASDAQ:REGN) is: Value: B, Growth: B, Momentum: B, Sentiment: A, Safety: B, Financials: B, and AI: B.

Regeneron Pharmaceuticals (NASDAQ:REGN) has a Due Diligence Score of 47, which is 23 points higher than the biotech industry average of 24.

REGN passed 18 out of 38 due diligence checks and has strong fundamentals. Regeneron Pharmaceuticals has seen its stock return 37.48% over the past year, overperforming other biotech stocks by 133 percentage points.

Regeneron Pharmaceuticals has an average 1 year price target of $904.29, a downside of -5.36% from Regeneron Pharmaceuticals's current stock price of $955.47.

Regeneron Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 24 analysts covering Regeneron Pharmaceuticals, 58.33% have issued a Strong Buy rating, 8.33% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Fennec Pharmaceuticals (NASDAQ:FENC)

Fennec Pharmaceuticals (NASDAQ:FENC) is the #3 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Fennec Pharmaceuticals (NASDAQ:FENC) is: Value: C, Growth: B, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: C.

Fennec Pharmaceuticals (NASDAQ:FENC) has a Due Diligence Score of 50, which is 26 points higher than the biotech industry average of 24.

FENC passed 17 out of 33 due diligence checks and has strong fundamentals. Fennec Pharmaceuticals has seen its stock return 51.11% over the past year, overperforming other biotech stocks by 147 percentage points.

Fennec Pharmaceuticals has an average 1 year price target of $16.67, an upside of 43.43% from Fennec Pharmaceuticals's current stock price of $11.62.

Fennec Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Fennec Pharmaceuticals, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 8 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Rallybio (NASDAQ:RLYB)

Rallybio (NASDAQ:RLYB) has an annual dividend yield of 86.26%, which is 73 percentage points higher than the biotech industry average of 12.82%.

Rallybio's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 6.74%, which is -6 percentage points lower than the biotech industry average of 12.82%.

Oramed Pharmaceuticals's dividend payout ratio of 7.1% indicates that its high dividend yield is sustainable for the long-term.

3. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 4.45%, which is -8 percentage points lower than the biotech industry average of 12.82%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 48.3% indicates that its high dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.68% in the last day, and up 0.7% over the last week. Oragenics was the among the top losers in the biotechnology industry, dropping -42.86% yesterday.

Oragenics shares are trading lower. The stock initially rallied yesterday after the company announced it had been granted an extension to regain NYSE compliance, but it has since reversed.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 42 points higher than the biotech industry average of 15. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -1.55% in the past year. It has overperformed other stocks in the biotech industry by 94 percentage points.

2. Innoviva (NASDAQ:INVA)

Innoviva (NASDAQ:INVA) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Innoviva has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Innoviva's stock has dropped -14.28% in the past year. It has overperformed other stocks in the biotech industry by 81 percentage points.

3. Zevra Therapeutics (NASDAQ:ZVRA)

Zevra Therapeutics (NASDAQ:ZVRA) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Zevra Therapeutics has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Zevra Therapeutics's stock has dropped -1.63% in the past year. It has overperformed other stocks in the biotech industry by 94 percentage points.

Are biotech stocks a good buy now?

62.71% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 79.98% over the next year.

2.25% of biotech stocks have a Zen Rating of A (Strong Buy), 3.83% of biotech stocks are rated B (Buy), 44.82% are rated C (Hold), 36.71% are rated D (Sell), and 12.39% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 18.56x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Xeris Biopharma Holdings (NASDAQ:XERS)

2. Regeneron Pharmaceuticals (NASDAQ:REGN)

3. Fennec Pharmaceuticals (NASDAQ:FENC)

1. Rallybio (NASDAQ:RLYB)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Innoviva (NASDAQ:INVA)

3. Zevra Therapeutics (NASDAQ:ZVRA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Xeris Biopharma Holdings (NASDAQ:XERS)

2. Regeneron Pharmaceuticals (NASDAQ:REGN)

3. Fennec Pharmaceuticals (NASDAQ:FENC)

1. Rallybio (NASDAQ:RLYB)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Innoviva (NASDAQ:INVA)

3. Zevra Therapeutics (NASDAQ:ZVRA)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.